Inventor · disambiguated record
Matthew John Meyer
Also filed as: MEYER MATTHEW · MEYER MATTHEW JOHN
8 granted patents·8 pending applications·34 citations·filing 2014–2024
84Inventor score
Top patents by PatentIndex Score
16 records- 0189US10973829B2Therapeutic uses of a C-RAF inhibitorNOVARTIS AG·Filed 2017·Granted Apr 13, 2021·4 cites·12 claims
- 0289US10786578B2CKIT antibody drug conjugatesNOVARTIS AG·Filed 2015·Granted Sep 29, 2020·4 cites·12 claims
- 0386US9415118B2Antibody drug conjugatesBATT JULIE LYNN·Filed 2014·Granted Aug 16, 2016·9 cites·24 claims
- 0485US12011449B2Therapeutic combinations comprising a c-RAF inhibitorNOVARTIS AG·Filed 2021·Granted Jun 18, 2024·1 cites·8 claims
- 0579US9498532B2Antibody drug conjugatesBATT DAVID BRYANT·Filed 2014·Granted Nov 22, 2016·8 cites·32 claims
- 0678US10238748B2Anti-CDH6 antibody drug conjugatesBIALUCHA CARL ULI·Filed 2015·Granted Mar 26, 2019·5 cites·7 claims
- 0775US9982045B2Anti-CDH6 antibody drug conjugatesBIALUCHA CARL ULI·Filed 2015·Granted May 29, 2018·3 cites·20 claims
- 0864US2025215087A1Combination therapy of kras inhibitor and treg depleting agentBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0960US11833215B2CKIT antibody drug conjugatesNOVARTIS AG·Filed 2020·Granted Dec 5, 2023·0 cites·17 claims
- 1057US2025268900A1Combination therapy using a substituted pyrimidin-4(3h)-one and nivolumab as well as its use in the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1152US2017008964A1Antibody drug conjugatesBATT DAVID BRYANT·Filed 2016·Application pending·0 cites
- 1250US2019345250A1Antibody drug conjugatesBATT DAVID BRYANT·Filed 2018·Application pending·0 cites
- 1348US2021121460A1A triple pharmaceutical combination comprising dabrafenib, trametinib and an erk inhibitorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1438US2017106095A1Antibody drug conjugatesBATT DAVID BRYANT·Filed 2016·Application pending·0 cites
- 1538US2021040205A1Antibodies targeting cd32b and methods of use thereofNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1636US2017198040A1ANTIBODIES TARGETING CD32b AND METHODS OF USE THEREOFNOVARTIS AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew John Meyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →